Metadichol as a MRSA Treatment—Case Study

Antibiotic resistant superbugs have been associated with an excess of adverse health conditions. MRSA, a drug-resistant bacterium, is associated with skin disorders such as abscesses and wound infections. The bacteria are also linked to the onset of pneumonia and can ultimately result in sepsis (bloodstream infections).  MRSA infections account for 18,650 deaths in the U.S. in 2005 (Over 80,000 invasive MRSA infections and 11,285 related deaths per year in 2011).

Once again, Metadichol has been effective in treating a very serious disease.  In the case study, the patient used only Metadichol to treat the MRSA infection.  It took only 21 days for it to be completely healed.  Please fill free to download the case study as a pdf file: MRSA-Final

“Metadichol® and MRSA Infections: A Case Report” PR Raghavan, Raghavan, J Infect Dis Ther 2017, 5:2
Metadichol® is a nanoemulsion of long-chain alcohols called as Policosanol and is present in foods such as rice, sugar cane, wheat, and peanuts. Metadichol® acts on Nuclear Vitamin D receptors (VDR) that have a ubiquitous presence in cells and tissues of the body to stimulate the immune system and inhibit a variety of disease processes, resulting from viral, bacterial and parasitic infections. Infectious agents can cause disease by avoiding normal host defense mechanisms or by subverting them to promote their replication. They do so by blocking VDR receptor that is responsible for innate immunity, and this suppression of the immune response leads to persistent infections.

We present a case study of a patient who had acquired MRSA infections and how Metadichol® by its actions on the VDR has resolved the problem of this deadly disease without any side effects.

 You may find all the articles and papers for download about Metadichol and various health conditions on my website.

MRSA is a very serious infection that is very difficult to treat.  I had a community acquired infection that started in February of 2009.  After many rounds of doxycycline, here is photo in the infected area in June (The infection is over an inch across). MRSA Photo 2 The infection persisted until I was on doxycycline for a continuous period from August through October (I don’t even want to think about what that did to my microbiome.).  The infection was very painful.  Unfortunately, there was no other treatment available at the time.   I had the infection for nine months and I was lucky that it did not enter my bloodstream.  I was fully replete in serum vitamin D with a level of over 80 ng/ml, 25(OH)D.  The action of the bacteria blocking the VDR is apparent.  If my level of vitamin D had not been high normal, I would hate to think of the outcome as sepsis was a real possibility.

Thank you Dr. Raghavan for developing this unique nanoemulsion that is basically a food substance in a form that is easily absorbed.  MRSA cases in the US are on decline as hospitals and gyms are more caring about sanitized surfaces that prevent spread of the infection.  In 2009, it was not unusual to see gym members walk away without wiping down equipment.  With new awareness of MRSA, all members at my gym wipe down the equipment before and after use.  Please be aware of areas of possible exposure, especially gyms and hospitals.    –Pandemic Survivor


Improved Longevity with Metadichol

Life Ext

Scientist at ETH Zurich and the Jena Hospital in Germany completed a study of over 40,000 genes and identified 30 that allowed for extended life span in worms, fish, and mice. Many of the genes extended life span by around 5%, but there was one gene that extended life by up to 25%: BCAT1.  Here’s the story.  It has long been a quest for humankind to extend life.  Here is a story of the Ponce de Leon’s of our era. There are several compounds that have been identified that impact the BACT1 gene.  A study is ongoing for the popular diabetes drug, Metformin, to extend life. To clarify, the BACT1 gene is responsible for catabolism of branched chain amino acids (BCAA).

When Metadichol (a nano version of policosanol) was compared to gabapentin and policosanol it was found to be 3000 times more effective than gabapentin in its impact on the BCAT1 gene.  Here is a link (pdf) to the paper “Improving Longevity with Metadichol by Inhibiting the BCAT1 Gene” for download Metadichol-BCAT1-paper .

It seems that the truth of extending life lies in the idea of having the least number of illnesses during your life.  I wrote an article about this some six years prior:  Filling Good, Looking Better.  In my reading, I think I came across this idea from Linus Pauling during the 70s in his book, “How to Live Longer and Feel Better.” Ideally, it is not just about extending life, the best solution is to have a healthy, vibrant life. Pauling promoted many ideas about how to be healthy (and by-the-way won two Nobel Prizes).  His largest push that he is remembered for is vitamin C.  His promotion of vitamin C has now been supported by modern research. However, he also promoted healthy eating and the reduction of sugar consumption, now a very modern idea.  He even did a study on prisoners to show that it was sugar and not fat that drove up cholesterol.  Long life by reducing disease appears to be the case for BCAAs as they impact your health on many levels.

The idea of extending life by reducing disease gets exciting when considering Metadichol. It appears to reduce disease on many different levels that just happen to include the metabolism of BCAA. Here are the many articles that I have written about Metadichol.  The beauty of Metadichol is that it is a food substance and not a drug and has no known side effects.

The idea is not to just extend your life span, it is to have a happy, healthy, and vibrant life.  To accomplish this: It is about understanding your emotions and living in flow; it is about eating a healthy diet that eliminates flour, sugar, and other processed foods; it is about getting adequate amounts of vitamins and minerals that are much higher than the RDAs of our government; it is about eliminating environmental toxins like nicotine, mercury, and the salt substitute MSG; and it is about eliminating the side effects from prescription drugs (In other words, stay healthy and don’t take prescription drugs).  To your healthy life that will allow you to live to 120 years old. –Pandemic Survivor 

Diabetes Solution – Metadichol

Sym DiabeticA novel approach to solving the issues of diabetes shows Metadichol to be a winner.  Dr. PR Raghavan had originally published a paper for a case study for type 1 diabetes, Case Report of Type 1 Diabetes. Journal of the Science of Healing Outcomes: 2010; Vol 2(8/9):24. After five years and ending treatment the patient is still producing insulin.

  He is now to publish in the Science of Healing Outcomes in July a case report for type 2 diabetes.  Metadichol and Type 2 Diabetes Case Report (Metadichol Type2 Diabetes). From the introduction: “Globally, it is estimated that 366 million people had diabetes in 2011 (5). The number of people with type 2 diabetes is rapidly increasing in every country and in some low to middle income countries, up to 80% of people have diabetes.”  This disease ravishes the body and ultimately causes death from organ failure.  It is a disease of poor eating habits: “Type 2 diabetes is a metabolic disease that can be prevented through lifestyle modification, diet control, and control of overweight and obesity. Education of the populace is still the key to control this emerging epidemic.”

Figure 8The results from the case study are amazing as the person was on no other meds, having chosen to use only Metadichol.  The figure 8 graph from the study shows a clear reduction in glucose as tested during various times throughout the day. The patient’s HbA1C was reduced from 9.8 at baseline to 6.2 at day 84.

Is Metadichol going to work for diabetics?  This is yet to be determined. This study of one person may have had significant changes in glucose because the person changed their eating and exercise habits.  Eating habits are not reported and do have a significant impact on type 2 diabetes.  However, the case study that was first reported for type 1 warrants a significant clinical trial to determine the efficacy for Metadichol for treating diabetes. Since policosanol (the primary component of Metadichol) is a food substance, this trial could be safely carried out on large populations with people that are willing to log their eating habits during the trial.

As reported in other articles on Metadichol, Dr. Raghavan believes that the effectiveness is from how nano-policosanol acts on the vitamin D receptor (VDR).  It appears to act as both an agonist and an inverse agonist which is very unusual.  In addition, Metadichol acts on many genes and other nuclear receptors as reported by Dr. Raghavan.  Will the medical community embrace a food substance for treating disease—all, yet to be determined?  – Pandemic Survivor

Extend Your Dog’s Life

sophieOur dog ages and we know the inevitable outcome. It is a trip to the vet and a long sad time after the dog has passed. However, it may be possible to extend the life of your dog. Our dog Sophie, 13, had a really tough time in the spring of 2014. It began with a urinary tract infection and resulting liver and kidney issues. After increasing the amount of vitamin D, sulfate as MSM, NAC, and changing the type of food she recovered. However, she was not the playful dog that we had known. In late November, we begin to supplement her diet with two sprays of Metadichol on her food. She has now returned to her old self and has become very playful. Also, as I have described in an earlier post, her lipomas are shrinking.

Last article, we reported the findings of Dr. Joe Marasco and his experience of Metadichol with his family. Now , here are his comments about experiences with his dogs and Metadichol. Read my other articles on Metadichol by selecting that category. – Pandemic Survivor

 One Dog’s Surprising Turnaround


My wife and I adopted our son’s dog named “Miles” about 6 months ago in January 2012, as our son was moving into an apartment that had a dog restriction. Miles is about 9 years old, and is a beagle and corgi mixed breed, 30 lbs., and a very mild mannered, non-aggressive and loving dog. His tests for Lyme disease have been negative. We treat our dogs as family members, and want to make sure that they have a safe and comfortable life in our household.

Miles had what appeared to be arthritis in one of his hind legs, and would get around by hobbling on his other three legs about 75% of the time, but the condition appeared to be worsening. His other hind leg was also giving him problems. He did not run. Upon taking him in, we thought his health would steadily go downhill to the point where he would need to be euthanized. We were expecting to have to proceed with that unpleasant event within a year.

I started giving Miles two small doses per week of Metadichol about two months ago. The doses were about one-fourth of a teaspoon of your liquid formulation, mixed in his normal food. There was no hesitation on his part to eat the dosed food, thereby suggesting that he was not able to detect any adverse odor or flavor.

Almost immediately, Miles’ activity level picked up. Where five months ago he would not be able to take a walk on a leash outside, he now actively is walking, running, and jumping. He now greets me by standing up on his back legs! He looks forward to daily walks.

I was told by his vet at a recent checkup in June 2012 that, exact quote: “there is nothing currently wrong with his joints.” When playing with other dogs outdoors (we have four dogs), he is able to run and keep up with the fastest.

This is a startling turnaround in his behavior, and friends and family who know Miles are stunned by his transformation. Only a few months ago was a dog that had to slowly limp to his water bowl is now outside chasing squirrels like a hound, and outrunning his younger peers. If nothing else, your product has given a new lease on an active life for Miles.


TazTazzy is a 14 year old Pomeranian with the kindest and most expressive disposition out of any of the many dogs we have raised. People say that he should be brought to nursing homes to snuggle and cheer up the residents that have little outside contact with the world. This photo is of Taz just as he was starting to become ill. It’s worth taking a close look at the expression in his eyes.

Taz’s kidneys had started to fail. We found this out after noticing that his behavior had changed from the frisky, bouncy, perpetually-moving, little ball of fur to a depressed and constantly tired shell of the dog he once was. This change happened over a one month time frame. Taz was brought to the vet for blood tests, which then confirmed the beginning of kidney failure. This was a death sentence, which we had sadly seen with a couple of our dogs in the past. The only realistic path forward leads to euthanasia. Usually the dogs with failing kidneys begin to sleep much more than usual, and lose any liveliness they usually have. They appear to be in constant discomfort, and begin to refuse to eat. Taz showed all of these symptoms in the matter of a few weeks, and lost so much weight (almost two pounds off of an eight pound dog!) that his ribs became prominent and were easily felt even under all of that fur. At the rate of this decline, it looked like that final trip to the animal hospital would be upon him within the next month.

With knowledge of the human responses seen with patients that had been treated with Metadichol, Taz was given a daily dose of about 3 mg in solution, sprayed onto his food each morning. On the third day after treatment started, a miracle in the making became apparent. His tail wagged again for the first time in weeks. He ran again for the first time in weeks. After one week of treatment, he began to act hungry once again and his food consumption doubled. Now, after 4 weeks of treatment, he is acting normal once again, is hungry like he should be, and runs and plays with the other 3 dogs, his “cousins,” that live in the same home with him. More blood tests will follow and we will compare the data.

If nothing else, with or without test data, it became obvious just after the third day of treatment that this tiny, gentle and loving dog was actually behaving like he felt better. Much better. Just this effect alone is incredible. I bet Taz would agree. You can see it in his once again wagging little tail. –Joseph M. Marasco, Ph.D.

Joe largeDr. Marasco, CEO of Diffinity Geonomics, is responsible for business development and company operations. Prior to joining Diffinity, he served from 2007-2012 as CEO and board member of Chiral Quest Corp., a US headquartered fine chemical and active pharmaceutical ingredient manufacturing firm. Dr. Marasco has served in several other leadership roles in both early stage and publicly traded firms including Dow Chemical and Beckman. He led the launch of Coenzyme Q-10 as a nutritional supplement in the US during the 1990’s while serving as Director of Kaneka’s pharmaceutical division (the original manufacturer of Q-10). He earned his Ph.D. in organic chemistry from University of Virginia, and was awarded a postdoctoral fellowship in Biochemistry at the Walter Reed Medical Center.